GOUT DISEASE TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Gout Disease Treatment Market - Overview The global Gout Disease Treatment Market, by Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Colchicine, Urate-lowering Agents, and Monoclonal Antibody), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 2,385.7 million in 2018, and is expected to exhibit a CAGR of 6.7%, during the forecast period (2019-2027), as highlighted in a new report published by . Increasing number of regulatory approvals for anti-gout drugs is expected to propel growth of the global gout disease treatment market over the forecast period. For instance, in February 2019, ROMEG Therapeutics received the U.S. FDA approval for Gloperba, a colchicine oral solution 0.6mg/5 ml. It is the first oral liquid solution of colchicine approved by the U.S. FDA. The drug is developed to prevent or treat gout attack. Moreover, in December 2015, AstraZeneca received the U.S. FDA approval for ZURAMPIC (lesinurad) 200 mg tablets. The drug, in combination with a xanthine oxidase inhibitor (XOI), is indicated for the treatment of hyperuricemia associated with gout. Browse 32 Market Data Tables and 35 Figures spread through 182 Pages and in-depth TOC on 'Gout Disease Treatment Market, by Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Colchicine, Urate-lowering Agents. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/goutdisease-treatment-market-3082 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Increasing adoption of inorganic strategies such as collaboration by key players operating in the-pharmaceutical industry is expected to drive the gout disease treatment market growth. For instance, in September 2019, Simcere Pharmaceutical Group and JW Pharmaceutical entered into a collaboration and exclusive license agreement for the development of anti-gout drug candidate URC-102 in China. Moreover, in January 2019, Horizon Pharma plc and HemoShear Therapeutics, LLC entered into a collaboration agreement to develop novel therapeutics for gout. Moreover, increasing number of pipeline products is expected to boost growth of the gout disease treatment market over the forecast period. For instance, in February 2017, the University of Alabama at Birmingham in collaboration with University of Auckland, New Zealand initiated phase 2 clinical trial to study the safety and efficacy of Denosumab, a fully human monoclonal antibody with a high affinity for RANKL, in addition to urate-lowering therapy (ULT), for the treatment of bone erosion associated with gout disease. This study is expected to be completed by February 2020. These factors are expected to drive growth of the gout disease treatment market over the forecast period. Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027‘ Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3082 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Key Takeaways of the Global Gout Disease Treatment Market: The global gout disease treatment market is expected to exhibit a CAGR of 6.7% during the forecast period (2019–2027), owing to increasing initiatives by major players for development of effective drugs for the treatment of gout. For instance, in February 2020, Dyve Biosciences, Inc. will initiate phase 2 clinical trial to demonstrate the safety and efficacy of DYV700 (drug candidate) after topical application, for the treatment of acute gout flares. Furthermore, increasing regulatory approvals of anti-gout drugs is expected to drive market growth over the forecast period. For instance, in September 2014, Hikma Pharmaceuticals received the U.S. FDA approval to commercialize its Mitigare, a colchicine capsule, to prevent gout attack. Major players operating in the global gout disease treatment market include AstraZeneca Plc, Takeda Pharmaceutical Company Limited, Novartis International AG, Teijin Pharma Limited, Simcere Pharmaceutical, JW Pharmaceutical Corporation, Horizon Therapeutics plc., Hikma Pharmaceuticals Plc, Ironwood Pharmaceuticals, Inc., CymaBay Therapeutics, Inc., and Zyla Life Sciences
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3082 Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved